Dopesh Raja Mulakala's most recent trade in Vanta Bioscience Ltd. was a Acquisition of 400,000 Equity Shares done at an average price of Rs. 50 . Disclosure was reported to the exchange on May 9, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Dopesh Raja Mulakala's has made SAST transactions in Vanta Bioscience Ltd. recently where a Acquisition of 800,000 shares done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanta Bioscience | Dopesh Raja Mulakala & Others | Promoter | Acquisition | 13 May 2025 | 800,000 | 5,178,000 (72.81%) | 12.68% | - | 06 May 2025 06 May 2025 |
SAST (29(2)) | - | Pref. Allotment | |
| Vanta Bioscience | Dopesh Raja Mulakala | Promoter & Director | Acquisition | 09 May 2025 | 400,000 | 858,000 (12.06%) | 5.62% | 50 | 20,000,000 | 06 May 2025 06 May 2025 |
Insider Trading | Equity Shares | Preferential Offer |